You are here

achondroplasia

Ascendis trial data piles pressure on BioMarin

BioPharma Dive

Wed, 09/18/24 - 01:42 pm

Ascendis Pharma

BridgeBio Stock Makes A Bullish Move On Dwarfism Treatment Results

Investors Business Daily

Tue, 06/4/24 - 11:42 am

5 Highly Anticipated FDA Decisions for Rare Diseases Coming This Year

BioSpace

Fri, 07/28/23 - 11:46 am

fibrodysplasia ossificans progressiva

Santhera Pharmaceuticals

BioMarin Answers BridgeBio's Challenge with sNDA for Achondroplasia

BioSpace

Wed, 03/8/23 - 09:42 am

BridgeBio Soars 64% And Breaks Out After Smashing Expectations In A Dwarfism Study

Investors Business Daily

Mon, 03/6/23 - 11:09 am

FDA approves first drug for genetic cause of dwarfism

Stat

Fri, 11/19/21 - 11:06 am

BioMarin stands tall with first approved drug for rare disease that causes dwarfism

MedCity News

Sat, 08/28/21 - 08:57 pm

BioMarin (BMRN) Files NDA for Vosoritide to Treat Dwarfism

Yahoo/Zacks.com

Fri, 08/21/20 - 11:56 am